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Abstract. Diagnostic uncertainty when considering prescription of antimicrobials (‘antibiotics’) in primary care
contributes to the major problem of microbial resistance. We conducted a feasibility evaluation of rapid testing for
leucocyte and differential count in two urban general practices, surveying the GPs online and interviewing them. GPs
reported that the machines were easy to use, the test results influenced their care and they would adopt the system if costs
were off-set. Feasibility, acceptability and perceived benefit justify a randomised trial to test the effect on antibiotic
prescribing rates and quality of care, with an economic evaluation to inform the cost-benefit.
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Introduction
Deciding whether to prescribe antibiotics is often difficult, and
GPs tend to err on the side of caution, prescribing more anti-
biotics than guidelines recommend (McCullough et al. 2017).
This might contribute to the antibiotic resistance crisis (O’Neill
et al. 2015; Australian Government 2018). In support of the
urgent need to reduce antibiotic use, there is an increasing focus
on general practice, where the greatest volumes of antibiotics are
prescribed for human use (Choosing Wisely Australia 2018;
NPS MedicineWise 2018).
One problem is that of diagnostic uncertainty in general
practice (Del Mar et al. 2017). Several near-patient testing
interventions, including C-reactive protein and procalcitonin,
have been shown to reduce antibiotic use (Tonkin-Crine et al.
2017), as has total leucocyte and differential count in a paediat-
ric practice (Casey et al. 2003; Casey and Pichichero 2009). GPs
report that they would like to have more point-of-care (POC)
tests available to them, including leucocyte count (Howick et al.
2014). Australian GPs’ low use of point-of-care tests that might
influence decisions about the prescribing of antibiotics may
result largely from a lack of support for this throughMedicare or
other public funding.
Hemocue WBC DIFF machines (www.hemocue.com/en/
solutions/hematology/hemocue-wbc-diff-system, accessed 16
September 2020), which provide total leucocyte and differential
counts in 5min from a finger-prick drop of blood, are being used
in remote health centres (Spaeth et al. 2015, 2019) and small
rural hospitals around Australia without on-site pathology
services (Radiometer Pacific, pers. comm.). The accuracy of
this machine has been confirmed (Simpson et al. 2009; Kok
et al. 2015). We wondered whether this test could be used by
urban GPs with a view to similarly support clinical decisions.
As a preliminary to formal testing of these objectives, we
decided to evaluate the feasibility, acceptability and perceived
utility of this system.
Specifically, we wanted to know whether GPs and practice
nurses could adapt the test to their workflow; whether and how
the results of the test changed care; and whether the system was
seen as valuable enough to use, if costs were not a problem.
The practice innovation
Method
The Australian distributor (Radiometer, Mount Waverley, Vic.,
Australia) installed four Hemocue WBC DIFF machines in two
urban general practices in Adelaide, South Australia, provided
all consumables andmaintained themachines. ParticipatingGPs
and practice nurses were trained in the use of the machines
during a 1-h meeting at each practice in March and April 2018,
respectively, which was run by Radiometer staff and Dr Oliver
Frank. GPs were free to use the machines until September 2018
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to perform total leucocyte and differential counts for any patient
that they wished.
We surveyed the GPs in late September 2018 using a Web-
based service (www.surveymonkey.com) using eight fixed-
response questions and one open-answer question, and inter-
viewedGPs and practice nurses in a group at each practice, audio
recording these and transcribing relevant parts of the interviews.
We obtained ethics approval (number H-2018–014) from the
University of Adelaide. All participants gave written informed
consent.
Results
Participation in the study was agreed by 14 of 29 GPs, two GP
registrars and 4 of 10 practice nurses. All 14 GPs completed the
online survey and 13GPs and four practice nurses participated in
the group interview. The registrars’ terms ended during the study
and they did not provide any feedback.
Approximately 95 tests were performed for patients during
the study. This equates to an average of one test per GP per
month. The responses to questions from the online survey are
shown in Table 1, and representative feedback given at the group
meeting interviews are shown in Box 1.
Most of the participating GPs found it easy to learn to
perform the tests and reported that the results influenced the
care they provided. They reported that the finding of a normal
white cell count and absence of neutrophilia was reassuring
to them and to patients, and that this influenced them not to
prescribe an antibiotic for patients for whom they otherwise
might have done so. They estimated that in routine care, they
would use one or two tests a day. However, to continue using the
test would require compensation for costs and time for testing.
Discussion
Our assumption that GPs and their practices could learn to use
the Hemocue WBC DIFF machine was found to be mostly
correct. We learned that the initial training was not enough to
enable some of the GPs and practice nurses to use the Hemocue
WBC DIFF machine successfully.
Our assumption that GPs would actually perform the white
cell counts for patients was also partly correct. Although it was
not mentioned in the survey or in the group interviews, we
gathered via informal discussions that in the rush of consulting,
the GPs often forgot that they had the Hemocue WBC DIFF
machine in their practice and they could have used it. We
believe that this is something that affects the uptake of many or
most new procedures and systems in general practice (Orchard
et al. 2019). In the cluster randomised controlled trial that
we propose, more intensive initial support and follow up of
participants, with continuing discussion at practice meetings,
will help to make POC testing of total leucocyte and differen-
tial counts a part of routine practice in intervention practices.
We learned that the 10 min or more required for the whole
testing process, including collecting the specimen, taking it to
the machine, running the test, reading the result and entering it
into the patient’s record, could not be accommodated within
current practice workflows.
Table 1. Responses from GPs to the online survey
Data are presented as n
Yes No
Did you learn to use the Hemocue WBC DIFF machine? 13 1
Very easy Easy Difficult
How easy or difficult was it to use the Hemocue WBC DIFF
machine?
1 10 2
Yes No
Did you use the Hemocue WBC DIFF machine for any of your
patients?
10 3
Yes No
Did using the HemocueWBCDIFFmachine change your care of
any of those patients?
4 1
I A practice nurse
Who collected most of the specimens and ran the WBC DIFF
tests for your patients who were tested?
9 1
Comments from representative feedback I prescribed an antibiotic for one
or more patients when I might
otherwise not have done so
I decided not to prescribe an antibiotic
for one or more patients when I had
been considering it (either because the
patient was asking for a prescription
or because I had thought that an anti-
biotic might be indicated)
It influenced
my care in
other ways
How did the results of the WBC DIFF test influence your care of
different patients? (Please choose as many as apply)
4 5 2
Yes No Unsure
If adequate funding was made available so that your time, your
practice nurse’s time, and all costs of having a Hemocue
machine and running it were paid for, would you continue to
use the Hemocue WBC DIFF machine?
6 2 1
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These results suggest GPs would find the test useful and
acceptable if the costs of the machine, consumables and time to
perform the tests were funded. Therefore, we suggest that a
randomised trial, with an economic evaluation, should be
instigated to quantify benefits (decrease in antibiotic use and
resistance, improved patient satisfaction), harms (serious out-
comes of infections such as those requiring hospital admission)
and costs.
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